Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00305058 · ClinicalTrials.gov registry record · Phase 2
Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain
A Phase 2 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 194
- Enrollment target
NCT00305058 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 194 participants.
The verdict
NCT00305058, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 194 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine which opiate pain medication (morphine or hydromorphone (Dilaudid)) is more effective in the treatment of acute pain in patients presenting to the emergency department.
Interventions
- DRUG Hydromorphone
- DRUG Morphine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00305058
The ClinicalTrials.gov registry entry for NCT00305058 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hydromorphone is the first listed.
NCT00305058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00305058 about?
NCT00305058 is a clinical study titled "Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain". The purpose of this research study is to determine which opiate pain medication (morphine or hydromorphone (Dilaudid)) is more effective in the treatment of acute pain in patients presenting to the emergency department.
What is the current status of trial NCT00305058?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 194 participants. The study started on 2005-07. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00305058?
The interventions under investigation include: Hydromorphone (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT00305058?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.